Feb 17 (Reuters) - Yumanity Therapeutics Inc YMTX.O :
* YUMANITY THERAPEUTICS EXPLORING STRATEGIC ALTERNATIVES TO
ENHANCE SHAREHOLDER VALUE AND ANNOUNCES RESTRUCTURING
* YUMANITY THERAPEUTICS INC - IN ADDITION, BOARD OF
DIRECTORS HAS
APPROVED A STRATEGIC RESTRUCTURING WITH OBJECTIVE OF PRESERVING
CAPITAL
* YUMANITY THERAPEUTICS INC - AS PART OF RESTRUCTURING,
COMPANY
ANTICIPATES ELIMINATING APPROXIMATELY 60% OF ITS WORKFORCE
* YUMANITY THERAPEUTICS INC - COMPANY ALSO EXPECTS TO INCUR
A
NON-RECURRING CHARGE OF APPROXIMATELY $0.4 MILLION IN Q1 OF 2022
RELATED TO RESTRUCTURING
Source text for Eikon: ID:nGNX9Sscxb
Further company coverage: YMTX.O
((Reuters.Briefs@thomsonreuters.com;))